European Hematology Association (EHA) Annual Congress - X4 Pharmaceuticals

European Hematology Association (EHA) Annual Congress

European Hematology Association (EHA) Annual Congress

June 2022

Mavorixafor Disrupts the Crosstalk Between Waldenström’s Macroglobulinemia Cells and the Bone Marrow Microenvironment Resulting in Enhanced Sensitivity to B-Cell–Targeted Therapies
Crispr/Cas9-Based Model of Heterozygous CXCR4WT/R334x Mutation to Study Cellular Phenotypes in WHIM Syndrome

© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy | Compliance and Ethics